These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 285569)

  • 21. Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
    Tamura Y; Matsuda Y; Yamada K; Takagi T; Nishikawa T; Watanabe M; Mikami K; Moriya H; Kumagai A
    Adv Exp Med Biol; 1979; 120B():515-24. PubMed ID: 517245
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
    Senba S; Konishi K; Saruta T; Ozawa Y; Kato E; Amagasaki Y; Nakata I
    Nephron; 1984; 37(4):257-63. PubMed ID: 6379486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of Bartter's syndrome--special reference to tubular function, the prostaglandin and the kallikrein-kinin system in the kidney].
    Ishiyama N; Kikuchi K; Oimatsu H; Nakao T; Takigami Y; Kondo A; Iimura O; Yamaguchi J
    Nihon Jinzo Gakkai Shi; 1985 Jan; 27(1):113-21. PubMed ID: 3847529
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome.
    Hornych A; Krief C; Aumont J
    Uremia Invest; 1985-1986; 9(2):203-10. PubMed ID: 3870249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A; Aurell M; Hansson L; Westberg G
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial Bartter's syndrome and the effect of indomethacin in one family member.
    Tsunoda S; Tsushima T; Nishioka T; Ohno N; Fukunaga T; Takano K; Yumura W; Shizume K; Branch RA
    J Urol; 1982 May; 127(5):1000-5. PubMed ID: 7086975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative and qualitative estimation of urinary kallikrein in a patient with Bartter's syndrome.
    Yamada K; Watanabe M; Nishikawa T; Mikami K; Shirai K; Tamura Y; Yamamoto M; Kumagai A; Matsuda Y; Moriya H
    Endocrinol Jpn; 1978 Dec; 25(6):583-9. PubMed ID: 751804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)].
    Nivet H; Rolland JC; Lebranchu Y; Dray F; Benatre A; Drucker J; Grenier B; Bagros P
    Nouv Presse Med; 1980 Apr; 9(18):1287-90. PubMed ID: 6990383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bartter's syndrome--abnormal prostaglandin production].
    Kono T
    Nihon Rinsho; 1978 May; Suppl():1530-1. PubMed ID: 691414
    [No Abstract]   [Full Text] [Related]  

  • 32. [The pathophysiological significance of increased renal kallikrein excretion in Bartter's syndrome (author's transl)].
    Sasaki H; Kawasaki T; Abe K
    Fukuoka Igaku Zasshi; 1978 Jan; 69(1):15-22. PubMed ID: 649033
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypokalemia, in Bartter's syndrome and other disorders, produces resistance to vasopressors via prostaglandin overproduction.
    Radfar N; Gill JR; Bartter FC; Bravo E; Taylor AA; Bowden RE
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):502-7. PubMed ID: 684024
    [No Abstract]   [Full Text] [Related]  

  • 34. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome.
    Watson ML; Gill JR; Branch RA; Oates JA; Brash AR
    Lancet; 1983 Aug; 2(8346):368-70. PubMed ID: 6135873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bartter's syndrome--a case study with special reference to the role of renal prostaglandins and the renin-angiotensin-aldosterone system].
    Sato M; Abe K; Hoshima M; Chiba S; Ritsu K
    Horumon To Rinsho; 1979 Jan; 27(1):51-7. PubMed ID: 428121
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of urinary prostaglandins in Bartter's syndrome.
    Zipser RD; Rude RK; Zia PK; Fichman MP
    Am J Med; 1979 Aug; 67(2):263-7. PubMed ID: 463932
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostacyclin overproduction in Bartter's syndrome.
    Güllner HG; Cerletti C; Bartter FC; Smith JB; Gill JR
    Lancet; 1979 Oct; 2(8146):767-9. PubMed ID: 90861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
    Verberckmoes R; van Damme B B; Clement J; Amery A; Michielsen P
    Kidney Int; 1976 Mar; 9(3):302-7. PubMed ID: 940272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of prostaglandins in the pathogenesis of Bartter's syndrome].
    Radó J; Simatupang T; Boer P; Mees EJ
    Orv Hetil; 1981 Jun; 122(25):1519-27. PubMed ID: 7312332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.